Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment-Reference-Cited by-同舟云学术

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment

Published:2019-12-13 Issue:12 Volume:2 Page:e1917363
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Garrett Stephanie L.¹,McDaniel Darius²,Obideen Malik²,Trammell Antoine R.³,Shaw Leslie M.⁴,Goldstein Felicia C.²,Hajjar Ihab⁵

Affiliation:

1. Division of General Medicine and Geriatrics, Department of Medicine, Wesley Woods Health Center, Emory University School of Medicine, Atlanta, Georgia

2. Department of Neurology, Emory Brain Health Center, Emory University School of Medicine, Atlanta, Georgia

3. Division of General Medicine and Geriatrics, Department of Medicine, Emory Brain Health Center, Emory University School of Medicine, Atlanta, Georgia

4. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia

5. Department of Neurology and Medicine, Emory Clinic at Executive Park, Emory Brain Health Center, Emory University School of Medicine, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2757481/garrett_2019_oi_190657.pdf

Reference21 articles.

1. Cerebrospinal fluid biomarkers for Alzheimer’s disease: a view of the regulatory science qualification landscape from the coalition against major diseases CSF biomarker team.;Arneric;J Alzheimers Dis,2017

2. CSF biomarkers of Alzheimer’s disease concord with amyloid-ß PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts.;Hansson;Alzheimers Dement,2018

3. Mild cognitive impairment due to Alzheimer disease in the community.;Petersen;Ann Neurol,2013

4. NIA-AA research framework: toward a biological definition of Alzheimer’s disease.;Jack;Alzheimers Dement,2018

5. Alzheimer’s disease in African Americans: risk factors and challenges for the future.;Barnes;Health Aff (Millwood),2014

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high‐risk cohort of middle‐aged adults;Alzheimer's & Dementia;2024-08-13

2. Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals;Nature Communications;2024-07-02

3. Overlooked cases of mild cognitive impairment: Implications to early Alzheimer’s disease;Ageing Research Reviews;2024-07

4. Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African Americans;Annals of Neurology;2024-06-25

5. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease;Nature Reviews Neurology;2024-06-12